--- title: "Perk Pharmaceuticals Ltd (530673) — Share Price, Financials & Analysis" symbol: "530673" company: "Perk Pharmaceuticals Ltd" canonical: "https://tapetide.com/stocks/530673" bse_code: "530673" sector: "Healthcare" industry: "Pharmaceuticals & Biotechnology" generated_at: "2026-09-13T18:39:23.274Z" --- # Perk Pharmaceuticals Ltd (530673) Canonical page: https://tapetide.com/stocks/530673 ## Company - **BSE Code:** 530673 - **Sector:** Healthcare - **Industry:** Pharmaceuticals & Biotechnology - **Macro Sector:** Healthcare - **Stock Type:** EQUITY - **Face Value:** ₹10 - **F&O Eligible:** No - **Website:** perkpharma.com ## About Perk Pharmaceuticals Ltd. engages in manufactures and markets specialty pharmaceuticals. ## Latest Price ## Key Insights ### Strengths - Company has reduced debt. - Company is almost debt free. ### Weaknesses - The company has delivered a poor sales growth of 1.20% over past five years. - Company has a low return on equity of 2.58% over last 3 years. - Company has high debtors of 588 days. - Company's cost of borrowing seems high ## Growth Rates | Metric | 1Y | 3Y | 5Y | | --- | --- | --- | --- | | net income growth | -79% | 31% | 16% | | revenue growth | -8% | -2% | 1% | ## Financial Statements ### Quarterly Results All figures in ₹ crore unless the row name says otherwise. | Item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | | Sales | 7.44 | 8.25 | 5.17 | 6.68 | 11.87 | 13.82 | 14.87 | | Expenses | 7.38 | 8.3 | 12.24 | 6.65 | 11.64 | 13.75 | 14.32 | | Operating Profit | 0.06 | -0.05 | -7.07 | 0.03 | 0.23 | 0.07 | 0.55 | | OPM % | 0.81 | -0.61 | -136.75 | 0.45 | 1.94 | 0.51 | 3.7 | | Other Income | 0.33 | 0.83 | -0.77 | 0.39 | 0.36 | 1.64 | 0.2 | | Interest | 0.02 | 0.12 | 0.06 | 0.34 | 0.18 | 0.03 | 0.03 | | Depreciation | 0.02 | 0.05 | -0.05 | 0.02 | 0.08 | 0.14 | 0.16 | | Profit before tax | 0.35 | 0.61 | -7.85 | 0.06 | 0.33 | 1.54 | 0.56 | | Tax % | 17.14 | 21.31 | -1.15 | -1116.67 | 33.33 | 13.64 | 14.29 | | Net Profit | 0.29 | 0.49 | -7.76 | 0.73 | 0.22 | 1.33 | 0.47 | | EPS in Rs | 0.69 | 0.33 | -5.24 | 0.49 | 0.14 | 0.86 | 0.3 | ### Profit & Loss All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | | --- | --- | --- | --- | --- | --- | --- | | Sales | 1.14 | 1.42 | 1.3 | 1.4 | 1.32 | 1.21 | | Expenses | 1.64 | 1.14 | 1.43 | 1.2 | 0.81 | 0.97 | | Operating Profit | -0.5 | 0.28 | -0.13 | 0.2 | 0.51 | 0.24 | | OPM % | -43.86 | 19.72 | -10 | 14.29 | 38.64 | 19.83 | | Other Income | 0 | 0 | 0.01 | 0 | 0 | 0 | | Interest | 0.04 | 0.05 | 0.02 | 0.03 | 0.04 | 0.03 | | Depreciation | 0.14 | 0.13 | 0.16 | 0.15 | 0.14 | 0.14 | | Profit before tax | -0.68 | 0.1 | -0.3 | 0.02 | 0.33 | 0.07 | | Tax % | 0 | 0 | 0 | 0 | 0 | 0 | | Net Profit | -0.68 | 0.1 | -0.3 | 0.02 | 0.33 | 0.07 | | Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | ### Balance Sheet All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | | --- | --- | --- | --- | --- | --- | --- | | Equity Capital | 6.38 | 6.38 | 6.38 | 6.38 | 6.38 | 6.38 | | Reserves | -2.61 | -0.85 | -1.15 | -1.13 | -0.79 | -0.72 | | Borrowings | 0.47 | 0.35 | 0.46 | 0.33 | 0.27 | 0.02 | | Other Liabilities | 1.07 | 0.99 | 0.85 | 0.42 | 0.85 | 1.4 | | Total Liabilities | 5.31 | 6.87 | 6.54 | 6 | 6.71 | 7.08 | | Fixed Assets | 2.87 | 4.39 | 4.17 | 4.02 | 3.88 | 3.82 | | CWIP | 0.08 | 0.08 | 0.1 | 0.1 | 0.1 | 0.1 | | Investments | 0 | 0 | 0 | 0 | 0 | 0 | | Other Assets | 2.36 | 2.4 | 2.27 | 1.88 | 2.73 | 3.16 | | Total Assets | 5.31 | 6.87 | 6.54 | 6 | 6.71 | 7.08 | ### Cash Flow All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | | --- | --- | --- | --- | --- | --- | --- | | Cash from Operating Activity | 0.02 | 0.15 | 0.03 | -0.08 | 0.05 | 0.58 | | Cash from Investing Activity | -0.03 | -0.01 | 0.03 | 0 | 0 | -0.08 | | Cash from Financing Activity | 0.01 | -0.12 | 0.11 | -0.13 | -0.05 | -0.25 | | Net Cash Flow | 0 | 0.02 | 0.17 | -0.21 | 0 | 0.25 | | Free Cash Flow | -0.01 | 0.14 | 0.06 | -0.08 | 0.05 | 0.5 | | CFO/OP | -4 | 54 | -23 | -40 | 10 | 242 | ### Ratios | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | | --- | --- | --- | --- | --- | --- | --- | | Debtor Days | 105.66 | 138.8 | 168.46 | 224.21 | 461.78 | 588.22 | | Inventory Days | 471.46 | 849.33 | 385.74 | 418.85 | 730 | 556.62 | | Days Payable | 117.86 | 224.62 | 153.47 | 149.59 | 343.53 | 766.5 | | Cash Conversion Cycle | 459.25 | 763.51 | 400.73 | 493.48 | 848.25 | 378.35 | | Working Capital Days | 361.8 | 323.87 | 314.46 | 362.39 | 503.26 | 437.4 | | ROCE % | — | 2.96 | -4.84 | 0.89 | 6.47 | 1.73 | ## Shareholding Pattern ### annual | Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Promoters | 52.98% | 52.98% | 52.98% | 52.98% | 52.98% | 52.98% | 52.99% | 52.99% | 63.64% | 63.39% | | FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.22% | 0.21% | | DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.18% | 0.17% | | Public | 47.01% | 47.01% | 47.02% | 47.01% | 47.01% | 47.02% | 47.01% | 47.01% | 35.96% | 36.22% | | No. of Shareholders | 70 | 56 | 51 | 46 | 55 | 54 | 55 | 60 | 144 | 204 | ### Quarterly | Category | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Promoters | 52.98% | 52.98% | 52.98% | 52.99% | 52.99% | 52.99% | 52.99% | 63.4% | 63.64% | 63.64% | 63.39% | 63.39% | | FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.2% | 0.22% | 0.22% | 0.21% | 0.21% | | DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.18% | 0.18% | 0.18% | 0.17% | 0.17% | | Public | 47.01% | 47.01% | 47.02% | 47.01% | 47.01% | 47.01% | 47.01% | 36.22% | 35.96% | 35.96% | 36.22% | 36.22% | | No. of Shareholders | 55 | 54 | 54 | 54 | 55 | 56 | 60 | 107 | 144 | 145 | 156 | 204 | ## Technical Indicators Derived from daily closing prices and recomputed each trading session; values move with the market. - **Overall Signal:** Strong Sell - **Buy / Neutral / Sell:** 4 / 5 / 10 ### Moving Averages — summary: **Strong Sell** | Indicator | Value | Signal | | --- | --- | --- | | SMA (10) | 4.01 | Buy | | EMA (10) | 4 | Buy | | SMA (20) | 4.05 | Sell | | EMA (20) | 4.12 | Sell | | SMA (50) | 4.76 | Sell | | EMA (50) | 4.89 | Sell | | SMA (100) | 6.4 | Sell | | EMA (100) | 6.68 | Sell | | SMA (200) | 11.14 | Sell | | EMA (200) | 9.84 | Sell | ### Oscillators — summary: **Neutral** | Indicator | Value | Signal | | --- | --- | --- | | RSI (14) | 39.29 | Neutral | | MACD (12,26,9) | -0.21 | Buy | | Stochastic (14,3,3) | 36.36 | Neutral | | ADX (14) | 50.52 | Buy | | Williams %R (14) | -45.45 | Neutral | | ATR (14) | 0.25 | High Volatility | | ROC (12) | -1.22 | Sell | | Stoch RSI (14) | 100 | Sell | | UO (7,14,28) | 49.04 | Neutral | ## Filings & Documents ### Other Documents | Date | Document | | --- | --- | | 28 January 2026 - Appointed official distributor for UltraProlink in North-East India and West Bengal, announced Jan 28, 2026. | [General Updates 28 January 2026 - Appointed official distributor for UltraProlink in North-East India and West Bengal, announced Jan 28, 2026.](https://nsearchives.nseindia.com/corporate/GRETEX_28012026114848_Intimation_under_Reg_30_-_Karaoke_Mic.pdf) | | 27 February 2026 - 27-Feb-2026: Board approved three subsidiaries; Gretex Aran 98%, Gretex Music Room 98%, Music Ecosystem 51%. | [Outcome of Board Meeting 27 February 2026 - 27-Feb-2026: Board approved three subsidiaries; Gretex Aran 98%, Gretex Music Room 98%, Music Ecosystem 51%.](https://nsearchives.nseindia.com/corporate/GRETEX_27022026175020_Outcome_of_BM_27022026.pdf) | | 2 March 2026 - Gretex Industries Limited has informed regarding a press release dated March 02, 2026, titled Gretex EZ Properties LLP Commences INM Franchise Operations in Mumbai . | [Press Release 2 March 2026 - Gretex Industries Limited has informed regarding a press release dated March 02, 2026, titled Gretex EZ Properties LLP Commences INM Franchise Operations in Mumbai .](https://nsearchives.nseindia.com/corporate/GRETEX_02032026190819_Intimation_under_Reg_30_Franchisee_under_subsidiary__1_.pdf) | | 2 February 2026 - 13,64,410 warrants at ₹236 each (₹32.20 crore); revising SEBI-format results; ₹11.00 crore LLP capital infusion. | [Reply to Clarification- Financial results 2 February 2026 - 13,64,410 warrants at ₹236 each (₹32.20 crore); revising SEBI-format results; ₹11.00 crore LLP capital infusion.](https://nsearchives.nseindia.com/corporate/GRETEX_17012026152853_Clarification_letter__2_.pdf) | | 17 February 2026 - Paid Rs1 Crore advance for property on behalf of proposed subsidiary Gretex Aran Properties LLP; completion within six months. | [General Updates 17 February 2026 - Paid Rs1 Crore advance for property on behalf of proposed subsidiary Gretex Aran Properties LLP; completion within six months.](https://nsearchives.nseindia.com/corporate/GRETEX_17022026181820_Intimation_under_Reg30.pdf) | | 16 January 2026 - Q3 and nine-month unaudited results; issued 13,64,410 warrants aggregating ₹32.20 crore; ₹8.05 crore received; ₹11 crore capital infusion. | [Updates 16 January 2026 - Q3 and nine-month unaudited results; issued 13,64,410 warrants aggregating ₹32.20 crore; ₹8.05 crore received; ₹11 crore capital infusion.](https://nsearchives.nseindia.com/corporate/GRETEX_16012026164339_Outcome_of_Meeting_09012026_signed.pdf) | | 14 February 2026 - Gretex Industries Limited has informed about General Updates | [General Updates 14 February 2026 - Gretex Industries Limited has informed about General Updates](https://nsearchives.nseindia.com/corporate/GRETEX_14022026155953_GIL_intimation_New_bus_in_EZ_prop.pdf) | | 10 March 2026 - Gretex incorporated Gretex Music Ecosystems Pvt Ltd on March 10, 2026; subscribed 51% (Rs.51,000). | [General Updates 10 March 2026 - Gretex incorporated Gretex Music Ecosystems Pvt Ltd on March 10, 2026; subscribed 51% (Rs.51,000).](https://nsearchives.nseindia.com/corporate/GRETEX_10032026190028_Intimation_under_Reg_30_Intimation_for_Gretex_Ecosystems_Pvt_Ltd__1_.pdf) | ### Annual Reports | Date | Document | | --- | --- | | from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27145_GRETEX_2024_2025_A_28072025201623.pdf) | | from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26338_GRETEX_2023_2024_18102024155544.pdf) | | from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23333_GRETEX_2022_2023_03092023232126_09042023070000.zip) | | from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/SME_AR_21551_GRETEX_2021_2022_06092022215042_09062022220008.zip) | | from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/SME_AR_19508_GRETEX_2020_2021_06092021182040_09062021190002.zip) | | from nse | [Financial Year 2020 from nse](https://archives.nseindia.com/annual_reports/SME_AR_17600_GRETEX_2019_2020_08092020114445_08092020120002.zip) | | from nse | [Financial Year 2019 from nse](https://archives.nseindia.com/annual_reports/SME_AR_15646_GRETEX_2018_2019_03092019145444_03092019150005.zip) | | from nse | [Financial Year 2018 from nse](https://archives.nseindia.com/annual_reports/SME_AR_13823_GRETEX_2017_2018_29092018183856.zip) | | from nse | [Financial Year 2017 from nse](https://archives.nseindia.com/annual_reports/SME_AR_12026_GRETEX_2016_2017_05102017173715.zip) | --- Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:39:23.274Z.